64
Views
0
CrossRef citations to date
0
Altmetric
Dermatology

The use of essential oils in atopic dermatitis: a review

ORCID Icon, , &
Pages 753-763 | Received 13 Oct 2023, Accepted 04 Apr 2024, Published online: 25 Apr 2024

References

  • Abuabara K, Magyari A, McCulloch CE, et al. Prevalence of atopic eczema among patients seen in primary care: data from the health improvement network. Ann Intern Med. 2019;170(5):354–356. doi: 10.7326/M18-2246.
  • Hadi HA, Tarmizi AI, Khalid KA, et al. The epidemiology and global burden of atopic dermatitis: a narrative review. Life (Basel). 2021;11(9):936. doi: 10.3390/life11090936.
  • Mayba JN, Gooderham MJ. Review of atopic dermatitis and topical therapies. J Cutan Med Surg. 2017;21(3):227–236. doi: 10.1177/1203475416685077.
  • Stevensen CJ. Aromatherapy in dermatology. Clin Dermatol. 1998;16(6):689–694. doi: 10.1016/s0738-081x(98)00058-3.
  • Urban K, Chu S, Giesey RL, et al. The global, regional, and national burden of atopic dermatitis in 195 countries and territories: an ecological study from the Global Burden of Disease Study 2017. JAAD Int. 2021;2:12–18. doi: 10.1016/j.jdin.2020.10.002.
  • Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1. doi: 10.1038/s41572-018-0001-z.
  • Dubin C, Del Duca E, Guttman-Yassky E. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Rev Clin Immunol. 2021;17(8):835–852. doi: 10.1080/1744666X.2021.1940962.
  • Agrawal R, Woodfolk JA. Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep. 2014;14(5):433. doi: 10.1007/s11882-014-0433-9.
  • Koh LF, Ong RY, Common JE. Skin microbiome of atopic dermatitis. Allergol Int. 2022;71(1):31–39. doi: 10.1016/j.alit.2021.11.001.
  • Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. doi: 10.1016/j.jaad.2014.03.023.
  • Kragballe K. Topical corticosteroids: mechanisms of action. Acta Derm Venereol Suppl. 1989;151:7–10, discussion 47–52.
  • Carr WW. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatr Drugs. 2013;15(4):303–310. doi: 10.1007/s40272-013-0013-9.
  • Paghdal KV, Schwartz RA. Topical tar: back to the future. J Am Acad Dermatol. 2009;61(2):294–302. doi: 10.1016/j.jaad.2008.11.024.
  • Hall A. Atlas of male genital dermatology. Switzerland: Springer International Publishing; 2019.
  • Nakashima C, Yanagihara S, Otsuka A, et al. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergol Int. 2022;71(1):40–46. doi: 10.1016/j.alit.2021.10.004.
  • Takahashi K, Miyake K, Ito J, et al. Topical application of a PDE4 inhibitor ameliorates atopic dermatitis through inhibition of basophil IL-4 production. J Invest Dermatol. In Press. doi: 10.1016/j.jid.2023.09.272.
  • Yim HJ, Jean T, Ong PY. Recent advances in immunomodulators for atopic dermatitis. Curr Opin Pediatr. 2023;35(6):671–679. doi: 10.1097/MOP.0000000000001279.
  • Calabrese L, Chiricozzi A, De Simone C, et al. Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis. Expert Opin Drug Metab Toxicol. 2022;18(5):347–355. doi: 10.1080/17425255.2022.2099835.
  • Kogame T, Egawa G, Kabashima K. Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies. Immunol Med. 2023;46(3):112–120. doi: 10.1080/25785826.2023.2214324.
  • Saeki H, et al. Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double‐blind, vehicle‐controlled trial. Br J Dermatol. 2022;1861:40–49.
  • Hiyama H, Arichika N, Okada M, et al. Pharmacological profile of difamilast, a novel selective phosphodiesterase 4 inhibitor, for topical treatment of atopic dermatitis. J Pharmacol Exp Ther. 2023;386(1):45–55. doi: 10.1124/jpet.123.001609.
  • Chu Z, Xu Q, Zhu Q, et al. Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis. Eur J Med Chem. 2021;213:113171. doi: 10.1016/j.ejmech.2021.113171.
  • Wood H, Chandler A, Nezamololama N, et al. Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis. Int J Dermatol. 2022;61(6):746–754. doi: 10.1111/ijd.15853.
  • Alves C, Penedones A, Mendes D, et al. The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis. Eur J Clin Pharmacol. 2022;78(12):1923–1933. doi: 10.1007/s00228-022-03400-4.
  • Ernst E. The role of complementary and alternative medicine. BMJ. 2000;321(7269):1133–1135. doi: 10.1136/bmj.321.7269.1133.
  • Bland J. Phytonutrition, phytotherapy, and phytopharmacology. Altern Ther Health Med. 1996;2(6):73–76.
  • Liu J, Mo X, Wu D, et al. Efficacy of a Chinese herbal medicine for the treatment of atopic dermatitis: a randomised controlled study. Complement Ther Med. 2015;23(5):644–651. doi: 10.1016/j.ctim.2015.07.006.
  • Kim M, Yun Y, Kim K S, et al. Three cases of atopic dermatitis in pregnant women successfully treated with Korean medicine. Complement Ther Med. 2013;21(5):512–516. doi: 10.1016/j.ctim.2013.07.008.
  • Hussain Z, Thu HE, Shuid AN, et al. Phytotherapeutic potential of natural herbal medicines for the treatment of mild-to-severe atopic dermatitis: a review of human clinical studies. Biomed Pharmacother. 2017;93:596–608. doi: 10.1016/j.biopha.2017.06.087.
  • Cai X, Sun X, Liu L, et al. Efficacy and safety of Chinese herbal medicine for atopic dermatitis: evidence from eight high-quality randomized placebo-controlled trials. Front Pharmacol. 2022;13:927304. doi: 10.3389/fphar.2022.927304.
  • Vieira BL, Lim NR, Lohman ME, et al. Complementary and alternative medicine for atopic dermatitis: an evidence-based review. Am J Clin Dermatol. 2016;17(6):557–581. doi: 10.1007/s40257-016-0209-1.
  • Maarouf M, Vaughn AR, Shi VY. Topical micronutrients in atopic dermatitis—an evidence-based review. Dermatol Ther. 2018;31(5):e12659. doi: 10.1111/dth.12659.
  • Kim G, Bae J-H. Vitamin D and atopic dermatitis: a systematic review and meta-analysis. Nutrition. 2016;32(9):913–920. doi: 10.1016/j.nut.2016.01.023.
  • Teo CWL, Tay SHY, Tey HL, et al. Vitamin E in atopic dermatitis: from preclinical to clinical studies. Dermatology. 2021;237(4):553–564. doi: 10.1159/000510653.
  • Patrizi A, Raone B, Neri I, et al. Randomized, controlled, double-blind clinical study evaluating the safety and efficacy of MD2011001 cream in mild-to-moderate atopic dermatitis of the face and neck in children, adolescents and adults. J Dermatolog Treat. 2016;27(4):346–350. doi: 10.3109/09546634.2015.1115814.
  • Evangelista MTP, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100–108. doi: 10.1111/ijd.12339.
  • De Belilovsky C, Roo-Rodriguez E, Baudouin C, et al. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatolog Treat. 2011;22(6):359–365. doi: 10.3109/09546634.2010.499932.
  • Hammond M, Gamal A, Damiani G, et al. Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis. Front Microbiol. 2022;13:944365. doi: 10.3389/fmicb.2022.944365.
  • Colombo D, Rigoni C, Cantù A, et al. Probiotics and prebiotics orally assumed as disease modifiers for stable mild atopic dermatitis: an Italian real-life, multicenter, retrospective, observational study. Medicina (Kaunas). 2023;59(12):2080. doi: 10.3390/medicina59122080.
  • Umborowati MA, Damayanti D, Anggraeni S, et al. The role of probiotics in the treatment of adult atopic dermatitis: a meta-analysis of randomized controlled trials. J Health Popul Nutr. 2022;41(1):37. doi: 10.1186/s41043-022-00318-6.
  • Herbert S, Haughton R, Nava J, et al. A review of topical probiotic therapy for atopic dermatitis. Clin Exp Dermatol. 2023;48(4):319–324. doi: 10.1093/ced/llac138.
  • Rusu E, Enache G, Cursaru R, et al. Prebiotics and probiotics in atopic dermatitis. Exp Ther Med. 2019;18(2):926–931. doi: 10.3892/etm.2019.7678.
  • Jang S-O, Kim H-J, Kim Y-J, et al. Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4+ CD25+ Foxp3+ T cells. Allergy Asthma Immunol Res. 2012;4(3):150–156. doi: 10.4168/aair.2012.4.3.150.
  • Enomoto T, Sowa M, Nishimori K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int. 2014;63(4):575–585. doi: 10.2332/allergolint.13-OA-0683.
  • Tatu AL, Ionescu MA, Clatici VG, et al. Bacillus cereus strain isolated from Demodex folliculorum in patients with topical steroid-induced rosaceiform facial dermatitis. An Bras Dermatol. 2016;91(5):676–678. doi: 10.1590/abd1806-4841.20165214.
  • Prakoeswa CRS, Bonita L, Karim A, et al. Beneficial effect of Lactobacillus plantarum is-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial. J Dermatolog Treat. 2022;33(3):1491–1498. doi: 10.1080/09546634.2020.1836310.
  • Drago L, Iemoli E, Rodighiero V, et al. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. Int J Immunopathol Pharmacol. 2011;24(4):1037–1048. doi: 10.1177/039463201102400421.
  • Iemoli E, Trabattoni D, Parisotto S, et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol. 2012;46 Suppl:S33–S40. doi: 10.1097/MCG.0b013e31826a8468.
  • Torii S, Torii A, Itoh K, et al. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children. Int Arch Allergy Immunol. 2011;154(3):236–245. doi: 10.1159/000321110.
  • Moroi M, Uchi S, Nakamura K, et al. Beneficial effect of a diet containing heat‐killed Lactobacillus paracasei K71 on adult type atopic dermatitis. J Dermatol. 2011;38(2):131–139. doi: 10.1111/j.1346-8138.2010.00939.x.
  • Matsumoto M, Ebata T, Hirooka J, et al. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2014;113(2):209–216.e7. doi: 10.1016/j.anai.2014.05.002.
  • Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9(378):4680. doi: 10.1126/scitranslmed.aah4680.
  • Myles IA, Earland NJ, Anderson ED, et al. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 2018;3(9):e120608. doi: 10.1172/jci.insight.120608.
  • Gueniche A, Knaudt B, Schuck E, et al. Effects of nonpathogenic gram‐negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double‐blind, placebo‐controlled clinical study. Br J Dermatol. 2008;159(6):1357–1363. doi: 10.1111/j.1365-2133.2008.08836.x.
  • Park SB, Im M, Lee Y, et al. Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: split-body clinical trial. Ann Dermatol. 2014;26(2):150–155. doi: 10.5021/ad.2014.26.2.150.
  • Myles IA, Williams KW, Reckhow JD, et al. Transplantation of human skin microbiota in models of atopic dermatitis. JCI Insight. 2016;1(10):e86955. doi: 10.1172/jci.insight.86955.
  • Myles IA, Castillo CR, Barbian KD, et al. Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair. Sci Transl Med. 2020;12(560):eaaz8631. doi: 10.1126/scitranslmed.aaz8631.
  • Zeldin J, Chaudhary PP, Spathies J, et al. Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Sci Adv. 2023;9(1):eade8898. doi: 10.1126/sciadv.ade8898.
  • Mooney E, Rademaker M, Dailey R, et al. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australas J Dermatol. 2015;56(4):241–251. doi: 10.1111/ajd.12313.
  • McDowell L, Olin B. Crisaborole: a novel nonsteroidal topical treatment for atopic dermatitis. J Pharm Technol. 2019;35(4):172–178. doi: 10.1177/8755122519844507.
  • Maleksabet SA, Keveyani Pooya H, Najafi M, et al. A review of aromatherapy in ancient Persia. Iran J Med Ethics Hist Med. 2016;8(5):33–43.
  • Cox-Georgian D, Ramadoss N, Dona C, et al. Therapeutic and medicinal uses of terpenes. In: Joshee N, Dhekney SA, Parajuli P, editors. Medicinal plants: from farm to pharmacy. Cham (Switzerland): Springer International Publishing; 2019. p. 333–359.
  • Noriega P. Terpenes in essential oils: bioactivity and applications. In: Terpenes and terpenoid—Recent advances. 2020. doi: 10.5772/intechopen.87558.
  • Rathod NB, Kulawik P, Ozogul F, et al. Biological activity of plant-based carvacrol and thymol and their impact on human health and food quality. Trends Food Sci Technol. 2021;116:733–748. doi: 10.1016/j.tifs.2021.08.023.
  • Sarkic A, Stappen I. Essential oils and their single compounds in cosmetics—a critical review. Cosmetics. 2018;5(1):11. doi: 10.3390/cosmetics5010011.
  • Sharmeen JB, Mahomoodally FM, Zengin G, et al. Essential oils as natural sources of fragrance compounds for cosmetics and cosmeceuticals. Molecules. 2021;26(3):666. doi: 10.3390/molecules26030666.
  • Fokou JBH, Dongmo PMJ, Boyom FF. Essential oil’s chemical composition and pharmacological properties, in essential oils-oils of nature. IntechOpen; 2020. doi: 10.5772/intechopen.86573.
  • Aljaafari MN, AlAli AO, Baqais L, et al. An overview of the potential therapeutic applications of essential oils. Molecules. 2021;26(3):628. doi: 10.3390/molecules26030628.
  • Hanif MA, Nisar S, Khan GS, et al. Essential oils. In: Malik S, editor. Essential oil research: trends in biosynthesis, analytics, industrial applications and biotechnological production. Cham (Switzerland): Springer International Publishing; 2019. p. 3–17.
  • Razali RM. The impact of elevated carbon dioxide on the stress tolerance of selected vegetable crops. Kuala Terengganu (Malaysia): Universiti Malaysia Terengganu; 2014.
  • Maddheshiya S, Ahmad A, Ahmad W, et al. Essential oils for the treatment of skin anomalies: scope and potential. S Afr J Bot. 2022;151:187–197. doi: 10.1016/j.sajb.2021.12.034.
  • Koyama S, Heinbockel T. The effects of essential oils and terpenes in relation to their routes of intake and application. Int J Mol Sci. 2020;21(5):1558. doi: 10.3390/ijms21051558.
  • Baptista-Silva S, Borges S, Ramos OL, et al. The progress of essential oils as potential therapeutic agents: a review. J Essent Oil Res. 2020;32(4):279–295. doi: 10.1080/10412905.2020.1746698.
  • Wojtunik-Kulesza KA. Toxicity of selected monoterpenes and essential oils rich in these compounds. Molecules. 2022;27(5):1716. doi: 10.3390/molecules27051716.
  • Xu Y, Ma L, Liu F, et al. Lavender essential oil fractions alleviate sleep disorders induced by the combination of anxiety and caffeine in mice. J Ethnopharmacol. 2023;302(Pt A):115868. doi: 10.1016/j.jep.2022.115868.
  • Cheng H, Lin L, Wang S, et al. Aromatherapy with single essential oils can significantly improve the sleep quality of cancer patients: a meta-analysis. BMC Complement Med Ther. 2022;22(1):187. doi: 10.1186/s12906-022-03668-0.
  • Panda S, Sahoo S, Tripathy K, et al. Essential oils and their pharmacotherapeutics applications in human diseases. Adv Tradit Med. 2020;22:1–5.
  • Parnes O. ‘Trouble from within’: allergy, autoimmunity, and pathology in the first half of the twentieth century. Stud Hist Philos Sci Part C Stud Hist Philos Biol Biomed Sci. 2003;34(3):425–454. doi: 10.1016/S1369-8486(03)00052-9.
  • Furue M, Terao H, Rikihisa W, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol. 2003;148(1):128–133. doi: 10.1046/j.1365-2133.2003.04934.x.
  • de Lavor ÉM, Fernandes AWC, de Andrade Teles RB, et al. Essential oils and their major compounds in the treatment of chronic inflammation: a review of antioxidant potential in preclinical studies and molecular mechanisms. Oxid Med Cell Longev. 2018;2018:6468593.
  • Zhang L, Liang X, Wang B, et al. Six herbs essential oils suppressing inflammatory responses via inhibiting COX-2/TNF-α/IL-6/NF-κB activation. Microchem J. 2020;156:104769. doi: 10.1016/j.microc.2020.104769.
  • Rai VK, Sinha P, Yadav KS, et al. Anti-psoriatic effect of lavandula angustifolia essential oil and its major components linalool and linalyl acetate. J Ethnopharmacol. 2020;261:113127. doi: 10.1016/j.jep.2020.113127.
  • Spisni E, Petrocelli G, Imbesi V, et al. Antioxidant, anti-inflammatory, and microbial-modulating activities of essential oils: implications in colonic pathophysiology. Int J Mol Sci. 2020;21(11):4152. doi: 10.3390/ijms21114152.
  • Sandner G, Heckmann M, Weghuber J. Immunomodulatory activities of selected essential oils. Biomolecules. 2020;10(8):1139. doi: 10.3390/biom10081139.
  • Wang V, Boguniewicz J, Boguniewicz M, et al. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126(1):3–12. doi: 10.1016/j.anai.2020.08.002.
  • Fjalstad JW, Esaiassen E, Juvet LK, et al. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother. 2017;73(3):569–580. doi: 10.1093/jac/dkx426.
  • Pauli A. Antimicrobial properties of essential oil constituents. Int J Aromather. 2001;11(3):126–133. doi: 10.1016/S0962-4562(01)80048-5.
  • Moleyar V, Narasimham P. Antibacterial activity of essential oil components. Int J Food Microbiol. 1992;16(4):337–342. doi: 10.1016/0168-1605(92)90035-2.
  • Dąbrowska JA. Essential oil from German chamomile (Matricaria chamomilla L.) and Roman chamomile (Chamaemelum nobile L.). Nauka, Badania i Doniesienia Naukowe; 2018. p. 71.
  • Soleimani M, Arzani A, Arzani V, et al. Phenolic compounds and antimicrobial properties of mint and thyme. J Herbal Med. 2022;36:100604. doi: 10.1016/j.hermed.2022.100604.
  • Abers M, Schroeder S, Goelz L, et al. Antimicrobial activity of the volatile substances from essential oils. BMC Complement Med Ther. 2021;21(1):124. doi: 10.1186/s12906-021-03285-3.
  • Angane M, Swift S, Huang K, et al. Essential oils and their major components: an updated review on antimicrobial activities, mechanism of action and their potential application in the food industry. Foods. 2022;11(3):464. doi: 10.3390/foods11030464.
  • Silverberg JI, Gelfand JM, Margolis DJ, et al. Pain is a common and burdensome symptom of atopic dermatitis in United States adults. J Allergy Clin Immunol Pract. 2019;7(8):2699–2706.e7. doi: 10.1016/j.jaip.2019.05.055.
  • Sutaria N, Adawi W, Goldberg R, et al. Itch: pathogenesis and treatment. J Am Acad Dermatol. 2022;86(1):17–34. doi: 10.1016/j.jaad.2021.07.078.
  • Happy AA, Jahan F, Momen MA. Essential oils: magical ingredients for skin care. J Plant Sci. 2021;9(2):54. doi: 10.11648/j.jps.20210902.14.
  • Wu Y-N, Xu Y, Yao L. Anti-inflammatory and anti-allergic effects of German Chamomile (Matricaria chamomilla L.). J Essent Oil Bear Plants. 2012;15(1):75–83. doi: 10.1080/0972060X.2012.10644022.
  • Arizmendi N, Alam SB, Azyat K, et al. The complexity of sesquiterpene chemistry dictates its pleiotropic biologic effects on inflammation. Molecules. 2022;27(8):2450. doi: 10.3390/molecules27082450.
  • de Souza Valente C, dos Santos G, Becker AG, et al. Anaesthetic effect of clove basil (Ocimum gratissimum L.) essential oil on the giant river prawn (Macrobrachium rosenbergii, De Man 1879) exposed to different water pHs. Aquacult Int. 2024;32:1493–1505. doi: 10.1007/s10499-023-01226-0.
  • Danby SG, Andrew PV, Taylor RN, et al. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis. Clin Exp Dermatol. 2022;47(6):1154–1164. doi: 10.1111/ced.15141.
  • Bialas I, Zelent-Kraciuk S, Jurowski K. The skin sensitisation of cosmetic ingredients: review of actual regulatory status. Toxics. 2023;11(4):392. doi: 10.3390/toxics11040392.
  • Darrell N. Essential oils: a concise manual of their therapeutic use in herbal and aromatic medicine. USA: Aeon Books; 2022.
  • Damiani G, Eggenhöffner R, Pigatto PDM, et al. Nanotechnology meets atopic dermatitis: current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature. Bioact Mater. 2019;4:380–386. doi: 10.1016/j.bioactmat.2019.11.003.
  • Muta T, Parikh A, Kathawala K, et al. Quality-by-design approach for the development of nano-sized tea tree oil formulation-impregnated biocompatible gel with antimicrobial properties. Pharmaceutics. 2020;12(11):1091. doi: 10.3390/pharmaceutics12111091.
  • Bisht A, Hemrajani C, Rathore C, et al. Hydrogel composite containing azelaic acid and tea tree essential oil as a therapeutic strategy for Propionibacterium and testosterone-induced acne. Drug Deliv Transl Res. 2022;12(10):2501–2517.
  • Shin YH, Hwang J, Kwon R, et al. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Allergy. 2023;78(8):2232–2254. doi: 10.1111/all.15807.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.